MBX Biosciences Inc. Common Stock
MBX | NASDAQ
$61.64
+$0.70 (+1.15%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 224K | 224K | 160K | 100K | n/a | n/a | n/a | n/a | n/a | 39K | 39K | 39K | 39K |
Gross Profit | -224K | -224K | -160K | -100K | n/a | n/a | n/a | n/a | n/a | -39K | -39K | -39K | -39K |
Operating Income | -117.92M | -98.79M | -98.06M | -90.87M | -86.56M | -81.41M | -68.19M | -59.58M | -50.91M | -42.26M | -28.94M | -18.95M | -8.01M |
Interest Income | 2.54M | 1.1M | n/a | 10.38M | 9.54M | 7.94M | 6.27M | 4.4M | 3.71M | 3.31M | 2.33M | 1.18M | 399K |
Pretax Income | -104.29M | -86.61M | -86.97M | -80.5M | -77.02M | -73.47M | -61.92M | -55.18M | -47.2M | -38.95M | -26.61M | -17.77M | -7.61M |
Net Income | -104.29M | -86.61M | -86.97M | -80.5M | -77.02M | -73.47M | -61.92M | -55.18M | -47.2M | -38.95M | -26.61M | -17.77M | -7.61M |
Selling & General & Admin | 29.43M | 23.56M | 18.9M | 16.25M | 14.46M | 12.64M | 10.78M | 9.66M | 8.66M | 7.9M | 5.63M | 3.37M | 1.49M |
Research & Development | 88.49M | 75.23M | 79.16M | 74.62M | 72.1M | 68.77M | 57.42M | 49.92M | 42.25M | 34.32M | 23.27M | 15.55M | 6.47M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 117.92M | 98.79M | 98.06M | 90.87M | 86.56M | 81.41M | 68.19M | 59.58M | 50.91M | 42.22M | 28.9M | 18.91M | 7.97M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 117.92M | 98.79M | 98.06M | 90.87M | 86.56M | 81.41M | 68.19M | 59.58M | 50.91M | 42.26M | 28.94M | 18.95M | 8.01M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 47.7M | 46.58M | 36.51M | 34.2M | 33.45M | 33.41M | 33.39M | 33.39M | 33.38M | 33.38M | 31.85M | 31.85M | 33.38M |
Shares Outstanding (Diluted) | 47.7M | 46.58M | 36.51M | 34.2M | 33.45M | 33.41M | 33.39M | 33.39M | 33.38M | 33.38M | 31.85M | 31.85M | 33.38M |
EPS (Basic) | -2.40 | -2.20 | -2.41 | -2.39 | -2.30 | -2.20 | -1.86 | -1.67 | -1.45 | -1.20 | -0.83 | -0.55 | -0.23 |
EPS (Diluted) | -2.40 | -2.20 | -2.41 | -2.39 | -2.30 | -2.20 | -1.86 | -1.67 | -1.45 | -1.20 | -0.83 | -0.55 | -0.23 |
EBITDA | -107.95M | -86.37M | -86.72M | -80.25M | -76.75M | -73.19M | -61.68M | -53.35M | -45.41M | -37.18M | -24.89M | -17.69M | -7.57M |
EBIT | -67.2M | -86.61M | -86.97M | -80.5M | -77.02M | -73.47M | -61.92M | -53.58M | -45.6M | -37.35M | -25.01M | -17.77M | -7.61M |
Depreciation & Amortization | 174K | 235K | 248K | 246K | 271K | 273K | 244K | 227K | 192K | 168K | 120K | 79K | 39K |
Add to Watchlist
Select watchlists to add or remove MBX